Cover Image
市場調查報告書

臨床決策支援系統的全球市場 - 至2021年的預測:服務,軟體,整合型,獨立式,知識密集型

Clinical Decision Support Systems Market by Component (Services, Software), Delivery Mode, Product Type (Integrated, Standalone), Model (Knowledge-Based), Type (Therapeutic, Diagnostic), User Interactivity, Application - Forecasts to 2021

出版商 MarketsandMarkets 商品編碼 296626
出版日期 內容資訊 英文 205 Pages
訂單完成後即時交付
價格
Back to Top
臨床決策支援系統的全球市場 - 至2021年的預測:服務,軟體,整合型,獨立式,知識密集型 Clinical Decision Support Systems Market by Component (Services, Software), Delivery Mode, Product Type (Integrated, Standalone), Model (Knowledge-Based), Type (Therapeutic, Diagnostic), User Interactivity, Application - Forecasts to 2021
出版日期: 2016年12月07日 內容資訊: 英文 205 Pages
簡介

臨床決策支援系統 (CDSS) 市場,預計從2016年的8億5630萬美元,到2021年擴大到15億1920萬美元。預計市場2016年∼2021年以12.2%的年複合成長率成長。

本報告提供全球臨床決策支援系統市場相關調查分析,市場概要,產業趨勢,各市場區隔的市場分析,競爭情形,主要企業等相關的系統性資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 全球臨床決策支援系統市場概要
  • 臨床決策支援系統市場:各模式
  • 臨床決策支援系統市場:各用戶雙向性
  • 臨床決策支援系統市場:各用途
  • 各地區概述:臨床決策支援系統市場

第5章 臨床決策支援系統的全球市場:概要

  • 簡介
  • 市場動態
    • 推動因素
    • 阻礙因素
    • 機會
    • 課題

第6章 臨床決策支援系統的全球市場:各零件

  • 簡介
  • 服務
  • 軟體
  • 硬體設備

第7章 臨床決策支援系統的全球市場:各提供方法

  • 簡介
  • Web基礎
  • 雲端基礎
  • 內部部署

第8章 臨床決策支援系統的全球市場:各產品

  • 簡介
  • 整合型
  • 獨立式

第9章 臨床決策支援系統的全球市場:各類型

  • 簡介
  • 治療
  • 診斷

第10章 臨床決策支援系統的全球市場:各模式

  • 簡介
  • 知識密集型
  • 非知識密集型

第11章 臨床決策支援系統的全球市場:各用戶雙向性

  • 簡介
  • 活性
  • 被動式

第12章 臨床決策支援系統的全球市場:各用途

  • 簡介
  • 傳統
  • 先進型

第13章 臨床決策支援系統的全球市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第14章 競爭情形

  • 概要
  • 主要企業比較分析
  • 競爭情形與趨勢

第15章 企業簡介

  • 簡介
  • CERNER CORPORATION
  • MCKESSON CORPORATION
  • EPIC SYSTEMS CORPORATION
  • MEDITECH
  • PHILIPS HEALTHCARE
  • WOLTERS KLUWER HEALTH
  • ZYNX HEALTH
  • ELSEVIER B.V.
  • IBM CORPORATION
  • ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.

第16章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: HIT 2237

The clinical decision support systems market is expected to reach USD 1,519.2 million by 2021 from USD 856.3 million in 2016, at a CAGR of 12.2% during the forecast period from 2016 to 2021. The government support and initiatives to drive adoption of HCIT solutions in healthcare, rising incidence of medication errors, rising prominence and usage of Big Data and m-Health tools, growing adoption of cloud computing in healthcare and prevalence of chronic diseases are some of the factors driving the growth of the clinical decision support systems market.

Clinical decision support systems are gaining popularity across the globe; the use of health information technologies and online resources in healthcare boosts clinical decision making by providing access to a wealth of information presented in a timely manner to make the best possible patient-specific decisions as per circumstances. These systems also reduce commission and omission errors and enhance the quality of care. The benefits offered by clinical decision support systems is driving stakeholders in the healthcare system including key industry players, healthcare providers and governments to take measures to integrate these systems into clinical workflows. However, reluctance amongst traditional healthcare providers to adopt the solutions, requirement of high investments for supporting IT infrastructure, data security concerns related to cloud-based systems and lack of interoperability are some of the factors expected to restrain the growth of this market.

On the other hand, emerging markets for healthcare IT in regions such as Asia-Pacific, Middle East, Latin America and Africa, and technological advancements in HCIT solutions offer growth opportunities for players in the market.

The clinical decision support systems market is expected to be challenged by the lack of skilled IT professionals in the healthcare sector.

Geographically, North America is expected to account for the largest share of the global clinical decision support systems market in 2016, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). The large share of the North American market is attributed to favorable initiatives and regulatory mandates, enterprises by key industry players, and rising incidence of medication errors in U.S.; and rising personalized medicine initiatives and prevalence of chronic diseases in Canada.

In-depth interviews were conducted with CEOs, Sales and Marketing Directors, other innovation and technology directors, and executives from various key organizations operating in the clinical decision support systems market place.

  • By Company Type: Tier 1: 50%, Tier 2: 35%, Tier 3: 15%
  • By Designation: Director Level: 29%, C-Level: 39%, Others: 32%
  • By Region: North America: 32%, Europe: 24%, APAC: 26%, ROW: 18%

The report includes the study of key players offering clinical decision support systems such as Cerner Corporation (U.S.), McKesson Corporation (U.S.), Epic Systems Corporation Inc. (U.S.), Medical Information Technology, Inc. (U.S.), Philips Healthcare (Netherlands), Allscripts Healthcare Solutions, Inc. (U.S.), Wolters Kluwer Health (U.S.), Zynx Health (U.S.), Elsevier B.V. (Netherlands), and International Business Machines (IBM) Corporation (U.S.)

Research Coverage:

The report segments the global clinical decision support systems market on the basis of component, delivery mode, product, type, model, user interactivity, application, and region, with analysis and forecasts to 2021.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms to garner a greater market share. Firms purchasing the report could use one or a combination of the below-mentioned five strategies for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the solutions offered by top players in the clinical decision support systems market. The report analyzes the clinical decision support systems market, by component, delivery mode, product, type, model, user interactivity, and application
  • Product Development/Innovation: Detailed insights on research and development activities and new product launches in the clinical decision support systems market
  • Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the clinical decision support systems market across regions
  • Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the clinical decision support systems market
  • Competitive Assessment: In-depth assessment of strategies, products, and distribution networks of the leading players in the clinical decision support systems market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH METHODOLOGY STEPS
  • 2.2. SECONDARY AND PRIMARY RESEARCH METHODOLOGY
    • 2.2.1. SECONDARY RESEARCH
      • 2.2.1.1. Key data from secondary sources
    • 2.2.2. PRIMARY RESEARCH
      • 2.2.2.1. Key industry insights
      • 2.2.2.2. Key data from primary sources
      • 2.2.2.3. Key insights from primary sources
  • 2.3. MARKET SIZE ESTIMATION METHODOLOGY
  • 2.4. MARKET DATA VALIDATION AND TRIANGULATION
  • 2.5. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

  • 3.1. INTRODUCTION
  • 3.2. CONCLUSION

4. PREMIUM INSIGHTS

  • 4.1. GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET OVERVIEW
  • 4.2. CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL (2016. VS. 2021)
  • 4.3. CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY USER INTERACTIVITY (2016. VS. 2021)
  • 4.4. CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION (2016. VS. 2021)
  • 4.5. GEOGRAPHIC SNAPSHOT: CLINICAL DECISION SUPPORT SYSTEMS MARKET

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. MARKET DRIVERS
      • 5.2.1.1. Government support and initiatives
      • 5.2.1.2. High prevalence of chronic diseases
      • 5.2.1.3. Growing incidence of medication errors
      • 5.2.1.4. Rising usage of Big Data and m-Health tools
      • 5.2.1.5. Growing adoption of cloud computing in healthcare
    • 5.2.2. MARKET RESTRAINTS
      • 5.2.2.1. Reluctance among traditional providers to adopt CDSS
      • 5.2.2.2. Requirement of high investments for IT infrastructure
      • 5.2.2.3. Data security concerns related to cloud-based CDSS
      • 5.2.2.4. Lack of interoperability
    • 5.2.3. MARKET OPPORTUNITIES
      • 5.2.3.1. Emerging markets for healthcare IT
      • 5.2.3.2. Technological advancements in healthcare IT solutions
    • 5.2.4. MARKET CHALLENGE
      • 5.2.4.1. Lack of skilled IT professionals in the healthcare industry

6. CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT

  • 6.1. INTRODUCTION
  • 6.2. SERVICES
  • 6.3. SOFTWARE
  • 6.4. HARDWARE

7. CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE

  • 7.1. INTRODUCTION
  • 7.2. WEB-BASED CLINICAL DECISION SUPPORT SYSTEMS
  • 7.3. CLOUD-BASED CLINICAL DECISION SUPPORT SYSTEMS
  • 7.4. ON-PREMISE CLINICAL DECISION SUPPORT SYSTEMS

8. CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT

  • 8.1. INTRODUCTION
  • 8.2. INTEGRATED CLINICAL DECISION SUPPORT SYSTEMS
  • 8.3. STANDALONE CLINICAL DECISION SUPPORT SYSTEMS

9. CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE

  • 9.1. INTRODUCTION
  • 9.2. THERAPEUTIC CLINICAL DECISION SUPPORT SYSTEMS
  • 9.3. DIAGNOSTIC CLINICAL DECISION SUPPORT SYSTEMS

10. CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL

  • 10.1. INTRODUCTION
  • 10.2. KNOWLEDGE-BASED CLINICAL DECISION SUPPORT SYSTEMS
  • 10.3. NON-KNOWLEDGE-BASED CLINICAL DECISION SUPPORT SYSTEMS

11. CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY USER INTERACTIVITY

  • 11.1. INTRODUCTION
  • 11.2. ACTIVE CLINICAL DECISION SUPPORT SYSTEMS
  • 11.3. PASSIVE CLINICAL DECISION SUPPORT SYSTEMS

12. CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION

  • 12.1. INTRODUCTION
  • 12.2. CONVENTIONAL CLINICAL DECISION SUPPORT SYSTEMS
  • 12.3. ADVANCED CLINICAL DECISION SUPPORT SYSTEMS

13. GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION

  • 13.1. INTRODUCTION
  • 13.2. NORTH AMERICA
    • 13.2.1. U.S.
      • 13.2.1.1. Favorable initiatives boosting the adoption of CDSS
      • 13.2.1.2. Growing healthcare spending in U.S.
      • 13.2.1.3. Regulatory mandates in the U.S.
      • 13.2.1.4. High medical error incidence
      • 13.2.1.5. Initiatives by industry players to advance clinical diagnosis
    • 13.2.2. CANADA
      • 13.2.2.1. Growing prevalence of chronic diseases in Canada
      • 13.2.2.2. Initiatives by Canada Health Infoway
      • 13.2.2.3. Rising personalized medicine initiatives in Canada
  • 13.3. EUROPE
    • 13.3.1. GERMANY
      • 13.3.1.1. Rising demand for advanced solutions and efficient healthcare delivery in Germany
      • 13.3.1.2. Presence of a strong insurance system, government initiatives to modernize the healthcare system in Germany
    • 13.3.2. U.K.
      • 13.3.2.1. Government Initiatives in the U.K.
    • 13.3.3. FRANCE
      • 13.3.3.1. Challenges in the French healthcare system
    • 13.3.4. ROE
  • 13.4. ASIA-PACIFIC
    • 13.4.1. INVESTMENTS AND REFORMS TO MODERNIZE CHINA'S HEALTHCARE INFRASTRUCTURE
    • 13.4.2. GROWING FOCUS ON HCIT IN CHINA
    • 13.4.3. MEASURES TO BOOST HEALTHCARE DELIVERY IN JAPAN
    • 13.4.4. RAPIDLY GROWING INDIAN HEALTHCARE INDUSTRY
    • 13.4.5. IMPLEMENTATION OF HCIT PROGRAMS IN AUSTRALIA
    • 13.4.6. GOVERNMENT INITIATIVES TO BOOST HCIT IN SINGAPORE
    • 13.4.7. GROWTH IN MEDICAL TOURISM
  • 13.5. ROW
    • 13.5.1. FAVORABLE ENVIRONMENT FOR THE GROWTH OF THE CDSS IN AFRICA
    • 13.5.2. RISING AWARENESS REGARDING HCIT SOLUTIONS IN BRAZIL
    • 13.5.3. MODERNIZATION OF HEALTHCARE SYSTEMS IN THE MIDDLE EAST

14. COMPETITIVE LANDSCAPE

  • 14.1. OVERVIEW
  • 14.2. COMPARATIVE ASSESSMENT OF KEY PLAYERS IN CDSS MARKET (2013-2016)
  • 14.3. COMPETITIVE SITUATION AND TRENDS
    • 14.3.1. PRODUCT DEPLOYMENT
    • 14.3.2. PRODUCT LAUNCHES, ENHANCEMENTS, AND INTEGRATION
    • 14.3.3. AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
    • 14.3.4. ACQUISITION
    • 14.3.5. OTHERS

15. COMPANY PROFILES (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

  • 15.1. INTRODUCTION
  • 15.2. CERNER CORPORATION
  • 15.3. MCKESSON CORPORATION
  • 15.4. EPIC SYSTEMS CORPORATION
  • 15.5. MEDITECH
  • 15.6. PHILIPS HEALTHCARE
  • 15.7. WOLTERS KLUWER HEALTH
  • 15.8. ZYNX HEALTH
  • 15.9. ELSEVIER B.V. (A DIVISION OF THE RELX GROUP)
  • 15.10. IBM CORPORATION
  • 15.11. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

16. APPENDIX

  • 16.1. DISCUSSION GUIDE
  • 16.2. OTHER DEVELOPMENTS
  • 16.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 16.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 16.5. AVAILABLE CUSTOMIZATIONS
  • 16.6. RELATED REPORTS
  • 16.7. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: RISING INCIDENCE OF MEDICATION ERRORS IS PROPELLING THE GROWTH OF THE GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET
  • TABLE 2: RELUCTANCE AMONG TRADITIONAL PROVIDERS TO ADOPT CDSS ACTS AS A KEY RESTRAINT TO MARKET GROWTH
  • TABLE 3: EMERGING MARKETS OFFER LUCRATIVE GROWTH POTENTIAL
  • TABLE 4: LACK OF SKILLED IT PROFESSIONALS IS A MAJOR CHALLENGE FOR THE GROWTH OF THE CDSS MARKET
  • TABLE 5: GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2014-2021 (USD MILLION)
  • TABLE 6: CLINICAL DECISION SUPPORT SERVICES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 7: CLINICAL DECISION SUPPORT SOFTWARE MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 8: CLINICAL DECISION SUPPORT HARDWARE MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 9: GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2014-2021 (USD MILLION)
  • TABLE 10: WEB-BASED CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 11: CLOUD-BASED CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 12: ON-PREMISE CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 13: GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 14: INTEGRATED CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 15: STANDALONE CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 16: GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 17: THERAPEUTIC CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 18: DIAGNOSTIC CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 19: GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY MODEL, 2014-2021 (USD MILLION)
  • TABLE 20: KNOWLEDGE-BASED CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 21: NON-KNOWLEDGE-BASED CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 22: GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY, 2014-2021 (USD MILLION)
  • TABLE 23: ACTIVE CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 24: PASSIVE CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 25: GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 26: CONVENTIONAL CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 27: ADVANCED CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 28: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 29: NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 30: NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY COMPONENT, 2014-2021 (USD MILLION)
  • TABLE 31: NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY DELIVERY MODE, 2014-2021 (USD MILLION)
  • TABLE 32: NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 33: NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 34: NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY MODEL, 2014-2021 (USD MILLION)
  • TABLE 35: NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY USER INTERACTIVITY, 2014-2021 (USD MILLION)
  • TABLE 36: NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 37: U.S.: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY COMPONENT, 2014-2021 (USD MILLION)
  • TABLE 38: U.S.: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY DELIVERY MODE, 2014-2021 (USD MILLION)
  • TABLE 39: U.S.: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 40: U.S.: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 41: U.S.: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY MODEL, 2014-2021 (USD MILLION)
  • TABLE 42: U.S.: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY INTERACTIVITY, 2014-2021 (USD MILLION)
  • TABLE 43: U.S.: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 44: CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY COMPONENT, 2014-2021 (USD MILLION)
  • TABLE 45: CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY DELIVERY MODE, 2014-2021 (USD MILLION)
  • TABLE 46: CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 47: CANADA.: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 48: CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY MODEL, 2014-2021 (USD MILLION)
  • TABLE 49: CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY INTERACTIVITY, 2014-2021 (USD MILLION)
  • TABLE 50: CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 51: EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 52: EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY COMPONENT, 2014-2021 (USD MILLION)
  • TABLE 53: EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY DELIVERY MODE, 2014-2021 (USD MILLION)
  • TABLE 54: EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 55: EUROPE.: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 56: EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY MODEL, 2014-2021 (USD MILLION)
  • TABLE 57: EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY USER INTERACTIVITY, 2014-2021 (USD MILLION)
  • TABLE 58: EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 59: GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY COMPONENT, 2014-2021 (USD MILLION)
  • TABLE 60: GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY DELIVERY MODE, 2014-2021 (USD MILLION)
  • TABLE 61: GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 62: GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 63: GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY MODEL, 2014-2021 (USD MILLION)
  • TABLE 64: GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY USER INTERACTIVITY, 2014-2021 (USD MILLION)
  • TABLE 65: GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 66: U.K.: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY COMPONENT, 2014-2021 (USD MILLION)
  • TABLE 67: U.K.: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY DELIVERY MODE, 2014-2021 (USD MILLION)
  • TABLE 68: U.K.: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 69: U.K.: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 70: U.K.: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY MODEL, 2014-2021 (USD MILLION)
  • TABLE 71: U.K.: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY USER INTERACTIVITY, 2014-2021 (USD MILLION)
  • TABLE 72: U.K.: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 73: FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY COMPONENT, 2014-2021 (USD MILLION)
  • TABLE 74: FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY DELIVERY MODE, 2014-2021 (USD MILLION)
  • TABLE 75: FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION) 118  
  • TABLE 76: FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 77: FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY MODEL, 2014-2021 (USD MILLION)
  • TABLE 78: FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY USER INTERACTIVITY, 2014-2021 (USD MILLION)
  • TABLE 79: FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 80: ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY COMPONENT, 2014-2021 (USD MILLION)
  • TABLE 81: ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY DELIVERY MODE, 2014-2021 (USD MILLION)
  • TABLE 82: ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 83: ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 84: ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY MODEL, 2014-2021 (USD MILLION)
  • TABLE 85: ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY USER INTERACTIVITY, 2014-2021 (USD MILLION)
  • TABLE 86: ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 87: APAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY COMPONENT, 2014-2021 (USD MILLION)
  • TABLE 88: APAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY DELIVERY MODE, 2014-2021 (USD MILLION)
  • TABLE 89: APAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 90: APAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 91: APAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY MODEL, 2014-2021 (USD MILLION)
  • TABLE 92: APAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY USER INTERACTIVITY, 2014-2021 (USD MILLION)
  • TABLE 93: APAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 94: ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY COMPONENT, 2014-2021 (USD MILLION)
  • TABLE 95: ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY DELIVERY MODE, 2014-2021 (USD MILLION)
  • TABLE 96: ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 97: ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 98: ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY MODEL, 2014-2021 (USD MILLION)
  • TABLE 99: ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY USER INTERACTIVITY, 2014-2021 (USD MILLION)
  • TABLE 100: ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION) 135  
  • TABLE 101: PRODUCT DEPLOYMENTS, 2013-2016
  • TABLE 102: PRODUCT LAUNCHES, ENHANCEMENTS, AND INTEGRATION, 2013-2016
  • TABLE 103: AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 2013-2016
  • TABLE 104: ACQUISITIONS, 2013-2016

LIST OF FIGURES

  • FIGURE 1: GLOBAL CDSS MARKET: RESEARCH METHODOLOGY STEPS
  • FIGURE 2: SAMPLING FRAME: PRIMARY RESEARCH
  • FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 5: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 6: RESEARCH DESIGN
  • FIGURE 7: DATA TRIANGULATION METHODOLOGY
  • FIGURE 8: SERVICES TO COMMAND THE LARGEST SHARE OF THE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, IN 2016
  • FIGURE 9: WEB-BASED CDSS TO DOMINATE THE MARKET, BY DELIVERY MODE, IN 2016
  • FIGURE 10: CLINICAL DECISION SUPPORT SYSTEMS FACILITATING ADVANCED APPLICATIONS TO REGISTER HIGHEST GROWTH IN THE FORECAST PERIOD
  • FIGURE 11: THERAPEUTIC CDSS TO DOMINATE THE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, DURING THE FORECAST PERIOD
  • FIGURE 12: ASIA-PACIFIC TO WITNESS THE HIGHEST MARKET GROWTH DURING THE FORECAST PERIOD
  • FIGURE 13: GOVERNMENT INITIATIVES DRIVING THE ADOPTION OF HCIT SOLUTIONS IS A KEY MARKET DRIVER
  • FIGURE 14: KNOWLEDGE-BASED CDSS TO DOMINATE THE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, IN 2016
  • FIGURE 15: ACTIVE CDSS TO DOMINATE THE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY USER INTERACTIVITY, IN 2016
  • FIGURE 16: CONVENTIONAL APPLICATIONS TO COMMAND THE LARGEST SHARE OF THE CLINICAL DECISION SUPPORT SYSTEMS MARKET IN 2016
  • FIGURE 17: ASIA-PACIFIC TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
  • FIGURE 18: CLINICAL DECISION SUPPORT SYSTEMS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 22: THERAPEUTIC SOLUTIONS TO ACCOUNT FOR THE LARGEST SHARE OF THE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, IN 2016
  • FIGURE 25: CONVENTIONAL CDSS TO ACCOUNT FOR THE LARGEST SHARE OF THE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, IN 2016
  • FIGURE 26: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2016
  • FIGURE 27: NORTH AMERICA: MARKET SNAPSHOT
  • FIGURE 28: EUROPE: MARKET SNAPSHOT
  • FIGURE 29: ASIA-PACIFIC: MARKET SNAPSHOT
  • FIGURE 30: ROW: MARKET SNAPSHOT
  • FIGURE 31: TOP FIVE DEVELOPMENTS, BY PLAYERS OVER THE LAST 3 YEARS (2013-2016)
  • FIGURE 32: BATTLE FOR MARKET SHARE: PRODUCT DEPLOYMENT, THE KEY STRATEGY ADOPTED BY MARKET PLAYERS (2013-2016)
  • FIGURE 33: GEOGRAPHICAL REVENUE MIX OF THE KEY PLAYERS IN THE CDSS MARKET (2015)
  • FIGURE 34: CERNER CORPORATION : COMPANY SNAPSHOT
  • FIGURE 35: MCKESSON CORPORATION: COMPANY SNAPSHOT 149  
  • FIGURE 36: ROYAL PHILIPS: COMPANY SNAPSHOT
  • FIGURE 37: WOLTERS KLUWER: COMPANY SNAPSHOT
  • FIGURE 38: RELX GROUP: COMPANY SNAPSHOT
  • FIGURE 39: IBM CORP.: COMPANY SNAPSHOT
  • FIGURE 40: ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: COMPANY SNAPSHOT
Back to Top